DOCSLIB.ORG

Philanthropic Support to Address Hiv/Aids in 2014

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Philanthropic Support to Address Hiv/Aids in 2014 PHILANTHROPIC SUPPORT TO ADDRESS HIV/AIDS IN 2014 The Mission of Funders Concerned About AIDS is to FCAA wishes to thank Broadway Cares/Equity Fights mobilize the leadership, ideas, and resources of funders to AIDS, Elton John AIDS Foundation UK, Open Society eradicate the global HIV/AIDS pandemic and to address Foundations, and the Ford Foundation for their generous its social and economic dimensions. funding of, and in-kind support for, this publication. The data, findings and conclusions presented in this report are FCAA envisions a world without AIDS, facilitated by a those of FCAA alone and do not necessarily reflect the philanthropic sector that works collaboratively, transparently, perspectives or the opinions of any of our funding partners. and urgently to ensure focused and robust funding for: • Evidence-based interventions in the treatment and FCAA is grateful for the efforts of the prevention of HIV infection; following people in ensuring the quality and comprehensiveness of this report: • Advocacy, research, and exploration of new methods to hasten the end of AIDS; and, • Erika Baehr, primary author • Investments that address the social inequities, health • Interns Thu Anh Vu Tran and Haley Kawaja disparities, and human rights abuses that fueled the • The FCAA Resource Tracking Advisory Committee: spread of the epidemic. Alicia Carbaugh, The Henry J. Kaiser Family Foundation; Erika Arthun, The Bill & Melinda Gates FCAA Board of Directors and Staff Foundation; Kevin Fisher and Emily Donaldson, AVAC; Michael Joyner, ViiV Healthcare; Sam Avrett, Fremont Center; Lyle Matthew Kan and Naa Hammond, Funders Andrea Flynn Krista Lauer Co-Chair Open Society Foundations for LGBTQ Issues; Sarah Tansey and Christen Dobsen, M•A•C AIDS Fund International Human Rights Funders Group. Julia Greenberg J. Channing Wickham Open Society Foundations • Funders for LGBTQ Issues and the International Co-Chair Human Rights Funders Group for their ongoing Cara Miller Washington AIDS Partnership Gilead Sciences guidance and collaboration. John Edmiston Gregorio Millett • Project Design Company, design Secretary amfAR, The Foundation for Kaiser Permanente AIDS Research FCAA thanks all the philanthropic entities that Daniel Jae-Won Lee Kathy Palumbo Immediate Past Chair responded to this year’s resource tracking surveys, The Community Foundation which provided the bulk of information for this Levi Strauss Foundation for Greater Atlanta publication. Thanks are also due to the Foundation Lisa Bohmer Shari Turitz Conrad N. Hilton Foundation American Jewish World Service Center for use of their data to supplement the U.S. section of the report. Alicia Carbaugh Louise van Deth The Henry J. Kaiser Family STOP AIDS NOW! Foundation Contact Funders Concerned About AIDS at: Alice Lin Fabiano STAFF 1100 Connecticut Avenue, NW, Suite 1200, Washington, Johnson & Johnson D.C. 20036 202-721-1196 202-882-2142 John L. Barnes Telephone: Fax: Shane Jenkins Executive Director Email: [email protected] Magic Johnson Foundation Website: www.fcaaids.org Sarah Hamilton Michael N. Joyner Director of Operations ViiV Healthcare © December 2015, Funders Concerned About AIDS Michael Kaplan Permission is granted to reproduce this document in part or AIDS United in its entirety, provided that Funders Concerned About AIDS Brook Kelly-Green (FCAA) is cited as the source for all reproduced material. This Ford Foundation document is posted and distributed primarily as an electronic condensed PDF file. Please feel free to contact FCAA if you would prefer printed copies of this report. TABLE OF CONTENTS [2] About This Report [6] Funding Context [3] Introduction [7] Geographic Focus [4] Overview [12] Corporate Funders [4] HIV/AIDS Philanthropic [13] Intended Use Disbursements 2007-2014 [15] Target Populations [5] Top 20 Philanthropic HIV/AIDS Funders in 2014 [17] Appendix 1: List of all Philanthropic [6] Distribution of Philanthropic Funders of HIV/AIDS in 2014 Funding by Funder Rank [26] Appendix 2: Methodology [28] Endnotes ACRONYMS AND ABBREVIATIONS Please visit the FCAA website at FCAA Funders Concerned About AIDS www.fcaaids.org/resourcetracking for an Global Fund Global Fund to Fight AIDS, online version of the report, and additional information including: Tuberculosis and Malaria • A press release and Q&A LGBTQ lesbian, gay, bisexual, transgender, • the full report methodology and questioning • full lists of 2014 intended use and target LMIC low- and middle-income countries populations by region. TA technical assistance Please visit www.aidsfundingmap.org for a TB tuberculosis searchable database of 2014 funding by region, UNAIDS Joint United Nations Program country and U.S. state. on HIV/AIDS U.S. United States Note: All figures marked $ are U.S. dollar amounts Table of Contents: Philanthropic Support to Address HIV/AIDS in 2014 1 ABOUT THIS REPORT Our 13th edition of Philanthropic Support to Address Where does this data show progress on the HIV/AIDS represents a new era for Funders Concerned philanthropic response to HIV/AIDS? Where are the About AIDS (FCAA). gaps? This report gives you the tools and opportunity to reflect on the impact behind the numbers, and drives While we have been analyzing the philanthropic response the critical conversations on where and how our sector to HIV/AIDS for more than a decade, our prior efforts can best innovate, strengthen, and advance the response. have offered only an aggregate, 50-thousand-foot view of This data will also become the driving force behind our the field. However, for FCAA to be an organization that future programming and outreach efforts, and will guide truly helps to leverage and align philanthropic resources our upcoming strategic review process. to address urgent and underfunded areas within the HIV/AIDS epidemic, we needed to unlock the data Finally, as we all know, HIV/AIDS does not exist in a necessary to advocate where those areas exist. vacuum, and neither does this project. We would like to thank our friends at the International Human Rights How is this year’s report different? We switched from Funders Group and Funders for LGBTQ Issues for surveying funders on their aggregate HIV funding totals to their outstanding thought partnership, inspiration, and analyzing individual grants submitted by funders within support of this work. This important collaboration has their full grants lists. We were overwhelmed by the allowed our organizations to be more mindful of not only response; not only in that we received 96% of our data as programming that happens at the intersections of HIV, detailed grants lists sent directly from participants, but human rights, and LGBTQ issues, but also the process in also by the level of data to which we now have access. which that work is analyzed and acknowledged. On page [The remaining data was supplemented from public 14 you can see the results of our careful attention to databases (such as The Foundation Center) and websites, those intersections. and via survey tools from organizations unable to share their grant lists.] This new methodology yielded grant-level Thank you to the organizations that participated in this and detail on more than 6,000 HIV/AIDS-related grants, and previous year’s reports. We welcome, and look forward to, offers deeper insight into the geographic, populations, input from readers about how to improve future editions of and strategy foci of the current private HIV/AIDS Philanthropic Support to Address HIV/AIDS. funding sector. On pages 8-9, for example, you can see top target populations by region. Page 10 offers data on the top U.S. region and state recipients of funding. We also know many international funders are concerned about shifting donor resources for HIV/AIDS in middle-income countries. Now, on page 7, you can find an analysis of private philanthropic funding for HIV/AIDS by country income level. This new methodology yielded grant-level detail on more“ than 6,000 HIV/AIDS-related grants, and offers deeper “insight into the geographic, populations, and strategy foci of the current private HIV/AIDS funding sector. 2 About This Report: Philanthropic Support to Address HIV/AIDS in 2014 INTRODUCTION A CALL TO ACTION This year’s Funders Concerned About AIDS (FCAA) has flourished on the violation of human rights of the resource tracking publication heralds an encouraging most vulnerable populations and inattention to the most headline: an 8% increase (to $618 million) in private impoverished regions. Even if HIV is someday eradicated, philanthropic funding for HIV/AIDS in 2014. without addressing root causes — such as poverty and marginalization — it would be a hollow victory when the But as is often the case, the full story is much more next wave of pandemic illness inevitably takes its place. complex than the headline. Despite the overall increase, The massive divestment of bilateral and multilateral private philanthropic funding for HIV/AIDS is down 8% resources, which now threatens decades of progress in from the high water mark of $674 million in 2008. This development efforts in middle-income countries, must year’s increase was mostly directed to the U.S. domestic serve as a call to action for private funders to invest epidemic, bringing private philanthropic funding for in community mobilization in those regions to hold HIV/AIDS in the U.S. to a new high of $139 million, governments accountable. Philanthropy must continue although the change is almost entirely attributable to to champion marginalized and criminalized populations, increased contributions to the U.S. from one funder. address stigma and discrimination, and employ effective Private funding given internationally from donors in the interventions that governments cannot or will not fund. U.S., Europe and Canada (for work in other countries or regions) has fallen each year since 2011 when it was first To do this work, we must rededicate ourselves to finding measured, decreasing 22% overall. needed resources. In 2008, the year of the global financial meltdown, private philanthropy contributed $674 million According to UNAIDS, in order to substantially bend the to HIV.
Load more

Recommended publications
  • Annual Report 2012 NSI NV
    annual report 2012 NSI N.V. annual report 2012 NSI N.V. 3 annual report NSI 2012 This version of NSI’s annual report is a translation of the original Dutch version. Although this English version has been compiled with the utmost care, in case of discrepancies between the English and the Dutch version, the Dutch version will prevail. Colofon This annual report is a publication by NSI. NSI Kruisweg 661-665 t +31 20 76 30 300 2132 NC Hoofddorp f +31 20 25 81 123 P.O. Box 3044 [email protected] 2130 KA Hoofddorp www.nsi.nl Editing and texts NSI Concept and design Bfocussed, Rotterdam Illustrations and icons Bfocussed, Rotterdam Prints Zwarthoed, Volendam Paper This publication is printed on PEFC certified paper. For additional information about NSI: www.nsi.nl 4 General data Supervisory Board H. Habas, chairman H.J. van den Bosch, secretary H.W. Breukink G.L.B. de Greef W.M. Steenstra Toussaint Management Board J. Buijs, ceo D.S.M. van Dongen, cfo General Meeting of Shareholders The General Meeting of Shareholders will be held on Friday 26 April 2013 at 10:30 am in Theatre Het Park, Westerdijk 4 in Hoorn. The agenda fort his meeting is available from the company. Financial Calendar 2013 AGM 26 April 2013 Publication first quarter results 2013 17 May 2013 Publication first half year results 2013 9 Augustus 2013 Publication third quarter results 2013 8 November 2013 Interim-dividends payments 2013 * Setting of final dividend for 2012 26 April 2013 Listing ex-dividend 30 April 2013 Payment of final dividend for 2012 8 May 2013 Setting of Q1 2013 interim
    [Show full text]
  • 1 0 0 0 C O M P a N Ie S T O in S P Ir E Eu R O
    1000 COMPANIES TO INSPIRE EUROPE INSPIRE TO COMPANIES 1000 2017 Our sponsors In association with www.1000companies.com LSEG London Stock Exchange Group Editorial Board Lauren Crawley-Moore (Head of Marketing Campaigns & Events); Alexandra Ritterman (Press Officer); Carolina Avanzini (Elite Growth Europe Associate); Damilola Alli (Marketing Associate) Contents Research & data verification and company profile editorial Business for Growth Ltd (organisers of the European Business Awards) Forewords www.businessawardseurope.com 4 A strengthened Capital Markets Union 58 Backing Europe’s SMEs to focus on the EU’s underperforming Michael Collins, CEO, Invest Europe IPO market 70 Dynamic SMEs need financing Valdis Dombrovkis, Vice-President European Sirpa Pietikäinen MEP, European Parliament Wardour Commission, Euro and Social Dialogue, Led by Claire Oldfield (Managing Director) and Ben Barrett (Creative Director). Financial Stability, Financial Services and CMU 82 Investing to meet the challenges ahead The team included: Matt Williams (Art Director); Rob Clark (Editor) and Wardour editorial; Othmar Karas MEP, European Parliament 5 Inside the report Jennifer Flower and Charlotte Tapp (Project Directors); John Faulkner and Jack Morgan (Production). Xavier Rolet KBE, CEO, 90 The Elite route to success Wardour, Drury House, 34–43 Russell Street, London, WC2B 5HA, United Kingdom London Stock Exchange Group Luca Peyrano, CEO, ELITE +44 (0)20 7010 0999 www.wardour.co.uk 8 Estonia will be committed to 108 Capital market finance remains helping SMEs neglected
    [Show full text]
  • "SOLIZE India Technologies Private Limited" 56553102 .FABRIC 34354648 @Fentures B.V
    Erkende referenten / Recognised sponsors Arbeid Regulier en Kennismigranten / Regular labour and Highly skilled migrants Naam bedrijf/organisatie Inschrijfnummer KvK Name company/organisation Registration number Chamber of Commerce "@1" special projects payroll B.V. 70880565 "SOLIZE India Technologies Private Limited" 56553102 .FABRIC 34354648 @Fentures B.V. 82701695 01-10 Architecten B.V. 24257403 100 Grams B.V. 69299544 10X Genomics B.V. 68933223 12Connect B.V. 20122308 180 Amsterdam BV 34117849 1908 Acquisition B.V. 60844868 2 Getthere Holding B.V. 30225996 20Face B.V. 69220085 21 Markets B.V. 59575417 247TailorSteel B.V. 9163645 24sessions.com B.V. 64312100 2525 Ventures B.V. 63661438 2-B Energy Holding 8156456 2M Engineering Limited 17172882 30MHz B.V. 61677817 360KAS B.V. 66831148 365Werk Contracting B.V. 67524524 3D Hubs B.V. 57883424 3DUniversum B.V. 60891831 3esi Netherlands B.V. 71974210 3M Nederland B.V. 28020725 3P Project Services B.V. 20132450 4DotNet B.V. 4079637 4People Zuid B.V. 50131907 4PS Development B.V. 55280404 4WEB EU B.V. 59251778 50five B.V. 66605938 5CA B.V. 30277579 5Hands Metaal B.V. 56889143 72andSunny NL B.V. 34257945 83Design Inc. Europe Representative Office 66864844 A. Hak Drillcon B.V. 30276754 A.A.B. International B.V. 30148836 A.C.E. Ingenieurs en Adviesbureau, Werktuigbouw en Electrotechniek B.V. 17071306 A.M. Best (EU) Rating Services B.V. 71592717 A.M.P.C. Associated Medical Project Consultants B.V. 11023272 A.N.T. International B.V. 6089432 A.S. Watson (Health & Beauty Continental Europe) B.V. 31035585 A.T. Kearney B.V.
    [Show full text]
  • Meet Your Bugaboo Fox GO TO: IMPORTANT INFORMATION
    GO TO: IMPORTANT INFORMATION meet your bugaboo fox GO TO: IMPORTANT INFORMATION 4x 4x 4x 4x 2 GO TO: IMPORTANT INFORMATION 3 GO TO: IMPORTANT INFORMATION A B F C G H D E I J K L M V N O P Q W R X S Y T U * product depicted may not be exactly the same in all regions 4 GO TO: IMPORTANT INFORMATION A. handlebar K. swivel wheel U. large wheel release button B. chassis L. integrated attachment point 1 V. sun canopy C. carry handle release button M. wrist strap W. square white knob D. large wheel N. apron X. unfolding lock E. underseat bag O. handlebar adjustment clip Y. suspension F. carry handle P. integrated attachment point 2 G. seat Q. bassinet stiffener H. harness R. bassinet/carrycot/pram body I. swivel wheel release button S. brake J. swivel wheel lock T. integrated attachment point 3 visual check OK visual check wrong audible click 1 2 3 Perform action on both sides of the product. 4 5 6 video available 7 5 GO TO: IMPORTANT INFORMATION When you see this symbol in the instructional part of the user guide, please refer to the warnings chapter for ensuring the safe use of the Bugaboo Fox. All the white parts of your Bugaboo Fox are functional. They’re the parts that allow you to adapt and change your Bugaboo Fox. 6 GO TO: IMPORTANT INFORMATION 16 22 19 26 20 28 31 34 35 36 38 40 41 43 44 8 GO TO: IMPORTANT INFORMATION 45 46 48 49 51 52 54 55 56 57 58 59 61 9 1 2 3 GO TO: IMPORTANT INFORMATION 4 5 6 7 33 34 35 36 37 38 39 4000 4x 4x 1 1 2 2 3 3 4 4 5 5 6 6 7 7 8 8 01 02 1 1 2 2 3 3 4 4 5 5 6 6 7 7 8 8 03 10 GO TO: IMPORTANT INFORMATION
    [Show full text]
  • Product Launch Improvement at Bugaboo International
    Product launch improvement at bugaboo international By André van Wijhe bachelor assignment André van Wijhe bugaboo international operations and innovations department September 2008 – June 2010 Amsterdam Zuid-Oost, The Netherlands Product launch improvement at bugaboo international Bachelor thesis final report André van Wijhe s0027871 Business Administration University of Twente First supervisor: Prof. dr. ir. P.C. de Weerd-Nederhof Second supervisor: Dr. ir. P. Terlouw Supervisor: R.J. Smeding - 1 - bachelor assignment André van Wijhe Preface - 2 - bachelor assignment André van Wijhe Management Summary Bugaboo international is a fast growing, young and innovative stroller company. Because of its explosive growth in the past couple of years, a structured NPD process has just been in use. A research concerning improvements of launch plans for bugaboo was the aim of this assignment. Therefore the central problem definition in this research is formulated as follows: For bugaboo it is unclear what good strategies are to launch new products. The focus of this research lies on the entire product portfolio of bugaboo international and this has resulted in the main question: What are good launch strategies for bugaboo? In this main question the word strategies embraces the entire launch plan of a new bugaboo product. With the use of interviews with bugaboo employees, a focus group meeting with a number of employees and a literature study on product launches, the necessary data was gathered. After an analysis, this resulted in the creation of the bugaboo launch model. That model represents the steps that need to be taken into account when launching a new bugaboo product.
    [Show full text]
  • Corporate 2010Annual Report En.Pdf
    THE GLOBAL FUND ANNUAL REPOrt 2010 ACKNOWLEDGEMENTS This report was written by Beatrice Bernescut, Ian Grubb, Ralf Jürgens and Paula Hacopian, with valuable contributions by Ian Carter, Eric Godfrey, Liam McDowall, Sunny Park and Rui Manuel Teixeira. Design and Layout: Art Gecko – [email protected] The geographical designations employed in this publication do not represent or imply any opinion or judgment on the part of the Global Fund to Fight AIDS, Tuberculosis and Malaria on the legal status of any country, territory, city or area, on its governmental or state authorities, or on the delimitation of its frontiers or boundaries. The mention of specific companies or of certain manufacturers, products does not imply that they are endorsed or recommended by the Global Fund in preference to others of a similar nature that are not mentioned. Inclusion of persons in photos should not be construed as indicating their health status. All rights reserved. This document may be freely reviewed, quoted, reproduced or translated, in part or in full, provided the source is acknowledged. The Global Fund accepts contributions from governments, corporations, foundations and individuals. To contribute, please visit our website or contact the External Relations team at [email protected]. For more information and updates on the status of the Global Fund, visit www.theglobalfund.org ISBN 978-92-9224-270-1 © The Global Fund to Fight AIDS, Tuberculosis and Malaria This report was published in May 2011. All information in this report relates to data as
    [Show full text]
  • Philanthropic Support to Address Hiv/Aids in 2015 Our Mission
    PHILANTHROPIC SUPPORT TO ADDRESS HIV/AIDS IN 2015 OUR MISSION The mission of Funders Concerned About AIDS (FCAA) is to mobilize the leadership, ideas, and resources of funders to eradicate the global HIV/AIDS pandemic and to address its social and economic dimensions. FCAA envisions a world without AIDS, facilitated by a philanthropic sector that works collaboratively, transparently, and urgently to ensure focused and robust funding for: Evidence-based interventions in the treatment and prevention of HIV infection; Advocacy, research, and exploration of new methods to hasten the end of AIDS; and, Investments that address the social inequities, health disparities, and human rights abuses that fueled the spread of the epidemic. FCAA BOARD OF DIRECTORS J. Channing Wickham Lisa Bohmer Gregorio Millett Chair Conrad N. Hilton Foundation amfAR, The Foundation Washington AIDS Partnership for AIDS Research Andrea Flynn Alice Lin Fabiano M•A•C AIDS Fund Kathy Palumbo Vice Chair The Community Foundation Julia Greenberg Johnson & Johnson for Greater Atlanta Open Society Foundations John Edmiston Shari Turitz Shane Jenkins Secretary American Jewish World Service Magic Johnson Foundation Kaiser Permanente Louise van Deth Michael N. Joyner Daniel Jae-Won Lee Aids Fonds/STOP AIDS NOW! ViiV Healthcare Treasurer Korab Zuka Levi Strauss Foundation Brook Kelly-Green Gilead Sciences Ford Foundation FCAA STAFF John L. Barnes Sarah Hamilton Caterina Gironda Executive Director Director of Operations Research & Communications Associate THANK YOU FCAA wishes to thank Broadway Erika Baehr, primary author private philanthropic funders engaged Cares/Equity Fights AIDS, Open Society in HIV/AIDS in Southern Africa, as well The FCAA Resource Tracking Advisory Foundations, and the Ford Foundation as all those funding organizations that Committee: Alicia Carbaugh, The for their generous funding of this participated.
    [Show full text]
  • Enabling the Energy Transition
    Alfen Annual Report 2020 Enabling the energy transition ALFEN N.V. Alfen magazine Contents 2020 at a glance 4 About Alfen 6 Report of the Management Board 10 Business review 12 Corporate Social Responsibility and non-financial information 18 2020 month-by-month 32 Financial performance 36 Risks and Uncertainties 44 Corporate governance 54 Report of the Supervisory Board 68 Financial statements 82 Consolidated financial statements 84 Company financial statements 132 Other information 146 10 68 82 Report of the Report of the Financial Management Supervisory statements Board Board 2 Contents Contents 2020 at a glance Eventful year due to the global COVID-19 pandemic Further internationalisation to Italy, Spain and Poland Revenue and other income (EUR) 189 million Expansion of EV charging (vs 143 million in 2019) production facilities and 100,000th Year-on-year revenue and other income growth EV charge point produced 32 percent (vs 41 percent in 2019) New innovations for all three Adjusted EBITDA as % of revenues business lines 12.9 percent (vs 10.1 percent in 2019) Strong ESG impact through Alfen’s renewed CSR strategy 4 Alfen - Annual Report 2017 Alfen - Annual Report 2017 5 About Alfen About Alfen Our growing business Smart grid solutions EV charging equipment Energy storage systems Alfen offers an in-house developed, Alfen offers an in-house developed Alfen offers an in-house developed produced and assembled range of and produced range of smart and and produced range of modular secondary transformer substations. connected electric vehicle (EV) energy storage systems for applica- In addition, we have in-house deve- chargers for use at home, office tions such as load balancing, peak loped and produced devices for grid and public locations.
    [Show full text]
  • B1cl9ittzus.Pdf
    bugaboo fox bugaboo runner bugaboo buffalo bugaboo donkey2 bugaboo donkey bugaboo bee5 bugaboo bee3 bugaboo bee bugaboo cameleon3 bugaboo cameleon bugaboo® breezy seat liner bugaboo® breezy seat liner bugaboo®-zračna sedežna prevleka bugaboo® breezy sædehynde bugaboo®-Sitzauflage mit lüftungsfenstern δροσερή επένδυση καθίσματος bugaboo® colchoneta integral ventilada bugaboo® bugaboo®-breezy istuintyyny coussin confort à fenêtres bugaboo® materassino del passeggino traspirante breezy bugaboo® bugaboo® breezy setetrekk wyściółka siedzenia breezy bugaboo® colchonete ventilada bugaboo® bugaboo® вентилируемый вкладыш на сиденье bugaboo® prodyšná vložka do sedačky bugaboo® breezy sittdyna bugaboo® hafif rüzgar koltuk kılıfı bugaboo® バガブー ブリージー・シートライナー bugaboo® breezy 시트라이너 bugaboo® 通风座垫 ®bugaboo רפידת המושב הנושמת של bugaboo cameleon3 bugaboo donkey2 bugaboo buffalo bugaboo runner bugaboo fox bugaboo cameleon bugaboo donkey 17 18 19 20 21 22 1 23 2 24 3 4 5 6 7 8 01 1 1 2 2 3 3 4 4 5 5 6 6 7 7 8 8 02 03 9 10 11 1 12 2 13 3 14 4 15 5 16 6 7 8 2x 04 05 2 1 17 2 18 3 19 4 20 5 21 6 22 7 23 8 24 06 07 1 1 2 2 3 3 4 4 5 5 6 6 7 7 2x 8 8 08 09 3 bugaboo bee5 bugaboo bee3 bugaboo bee 17 18 19 20 21 22 9 23 10 24 11 12 13 14 15 16 01 9 9 10 10 11 11 12 12 13 13 14 14 15 15 16 16 02 03 9 10 11 12 9 13 10 14 11 15 12 16 13 14 15 16 04 05 4 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 2x 06 07 17 18 19 20 21 22 23 24 9 10 11 12 13 14 15 16 2x 08 09 17 17 18 18 19 19 20 20 2121 22 22 23 23 24 24 10 5 17 17 18 18 19 19 20 20 21 21 22 22 23 23 24 24 17 18 19 20 21 22 23 2524 25 26 26 27 27 28 28 29 29 30 30 31 31 32 32 01 25 25 26 26 27 27 28 28 29 29 30 30 31 31 32 32 6 7 ® ® bugaboo breezy seat liner bugaboo breezy seat liner WARNINGS WAARSCHUWINGEN • Failure to review and heed all • Het niet bestuderen en niet in acht warnings and assembly nemen van alle waarschuwingen instructions could result in serious en montage-instructies kan bij uw injury to your child kind ernstig letsel veroorzaken.
    [Show full text]
  • Proxy Statement/Prospectus Accompanying This Letter Provide an Outline of the Business to Be Conducted at the FSK Special Meeting
    FS KKR Capital Corp. MERGER PROPOSED—YOUR VOTE IS VERY IMPORTANT Dear Fellow Stockholder, You are cordially invited to attend a special meeting of stockholders of FS KKR Capital Corp. (“FSK”), to be held on May 21, 2021 at 1:00 p.m., Eastern Time, at 201 Rouse Boulevard, Philadelphia, Pennsylvania 19112 (together with any adjournments or postponements thereof, the “FSK Special Meeting”). The Notice of Special Meeting of Stockholders and joint proxy statement/prospectus accompanying this letter provide an outline of the business to be conducted at the FSK Special Meeting. At the FSK Special Meeting, you will be asked to consider and vote upon: i. a proposal to approve the Agreement and Plan of Merger, dated as of November 23, 2020 (the “Merger Agreement”), by and among FSK, FS KKR Capital Corp. II (“FSKR”), Rocky Merger Sub, Inc., a wholly owned subsidiary of FSK (“Merger Sub”) and FS/KKR Advisor, LLC (the “Advisor”) and the transactions contemplated thereby, including the merger of Merger Sub with and into FSKR with FSKR as the surviving corporation (such proposal, the “FSK Merger Proposal”); ii. a proposal to approve the issuance of shares of FSK common stock (“FSK Common Stock”) to FSKR stockholders as merger consideration in the merger (such proposal, the “Merger Stock Issuance Proposal”); and iii. a proposal to amend the investment advisory agreement, dated December 20, 2018, by and between FSK and the Advisor (the “Existing FSK Investment Advisory Agreement”) to (1) reduce FSK’s income incentive fee rate from 20% to 17.5% and (2) remove the total return lookback provision applicable to the subordinated incentive fee on income (such proposal, the “FSK Advisory Agreement Amendment Proposal”).
    [Show full text]
  • STADA Delisting.Pdf
    Pflichtveröffentlichung gemäß § 14 Abs. 2 und 3 des Wertpapiererwerbs- und Übernahmegesetzes (WpÜG) in Verbindung mit § 39 Abs. 2 Satz 3 Nr. 1 des Börsengesetzes (BörsG) Aktionäre der STADA Arzneimittel Aktiengesellschaft, insbesondere mit Wohnsitz, Sitz oder gewöhnlichem Aufenthalt in den Vereinigten Staaten von Amerika oder anderweitig außerhalb der Bundesrepublik Deutschland, der Mitgliedstaa- ten der Europäischen Union und des Europäischen Wirtschaftsraums sollten die Hinweise in Ziffer 1 (Allgemeine Hin- weise zur Durchführung des Delisting-Erwerbsangebots) und Ziffer 13.8 (Inhaber von American Depositary Receipts) der Angebotsunterlage besonders beachten. ANGEBOTSUNTERLAGE ÖFFENTLICHES DELISTING-ERWERBSANGEBOT (BARANGEBOT) der Nidda Healthcare GmbH c/o STADA Arzneimittel Aktiengesellschaft Stadastraße 2-18 61118 Bad Vilbel Deutschland an die Aktionäre der STADA Arzneimittel Aktiengesellschaft Stadastraße 2-18 61118 Bad Vilbel Deutschland zum Erwerb sämtlicher von ihnen gehaltenen nennwertlosen Namensaktien (Stammaktien) der STADA Arzneimittel Aktiengesellschaft gegen eine Geldleistung in Höhe von EUR 81,73 je Aktie der STADA Arzneimittel Aktiengesellschaft Annahmefrist: 11. Oktober 2018 bis 8. November 2018, 24:00 Uhr (Ortszeit Frankfurt am Main) 18:00 Uhr (Ortszeit New York) STADA-Aktien: ISIN DE0007251803 Zum Verkauf Eingereichte STADA-Aktien: ISIN DE000A2NBUK2 INHALTSVERZEICHNIS 1. ALLGEMEINE HINWEISE ZUR DURCHFÜHRUNG DES DELISTING- ERWERBSANGEBOTS ...............................................................................................
    [Show full text]
  • Bugaboo Fox Bugaboo Runner Bugaboo Buffalo Bugaboo Donkey2 Bugaboo Donkey Bugaboo Bee5 Bugaboo Bee3 Bugaboo Bee Bugaboo Cameleon3 Bugaboo Cameleon
    bugaboo fox bugaboo runner bugaboo buffalo bugaboo donkey2 bugaboo donkey bugaboo bee5 bugaboo bee3 bugaboo bee bugaboo cameleon3 bugaboo cameleon bugaboo® light cotton blanket bugaboo® lichte katoenen deken bugaboo®-jemná vlnená prikrývka bugaboo® let bomuldstæppe bugaboo®-leichte baumwolldecke ελαφριά βαμβακερή κουβέρτα bugaboo® manta de algodón ligera bugaboo® bugaboo®-kevyt-puuvillahuopa couverture en coton léger bugaboo® copertina di cotone leggero bugaboo® bugaboo® lett bomullsteppe lekki bawełniany koc bugaboo® manta de algodão leve bugaboo® bugaboo® Легкое хлопчатобумажное одеяльце bugaboo® mehka volnena odeja bugaboo® lätt bomullsfilt bugaboo hafif pamuklu battaniye bugaboo® バガブー ライトコットンブ ランケット bugaboo® 라이트 코튼 블랭킷 bugaboo® 薄绵毯 ®bugaboo הלק הנתוכ תכימש 2 bugaboo cameleon3 bugaboo bee5 bugaboo donkey2 bugaboo buffalo bugaboo runner bugaboo fox bugaboo cameleon bugaboo bee3 bugaboo donkey bugaboo bee 3 ® The information contained herein is subject to change without bugaboo light cotton notice. Bugaboo International BV shall not be liable for blanket technical errors or omissions contained herein. The purchased product may differ from the product as described in this user guide. Our most recent user guides can be requested at our service departments or at www.bugaboo.com. WARNINGS © 2017 Bugaboo International BV. BUGABOO, BUGABOO CAMELEON, BUGABOO BEE, BUGABOO DONKEY, BUGABOO BUFFALO, RUNNER, BUGABOO FOX, BUGABOO • Read the user guide carefully BOXER and the Bugaboo logos are registered trademarks. The before you use the product and Bugaboo® strollers are patented and design protected. keep the guide for future reference. • Failure to follow these warnings bugaboo® lichte katoenen and the instructions could result in deken serious injury or death. • The blanket is only intended for WAARSCHUWINGEN use on strollers with seat units.
    [Show full text]